Drug Side Effects
Search
BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC
BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC
was reported 29 times
These drug classes are most commonly taken by patients reporting BLADDER TRANSITIONAL CELL CARCINOMA METASTATIC:
#
Drug
Count
0
Nonsteroidal Anti-inflammatory Drug [EPC]
3
1
Platelet Aggregation Inhibitor [EPC]
3
2
Sulfonylurea [EPC]
3
3
CD20-directed Cytolytic Antibody [EPC]
2
4
Corticosteroid [EPC]
2
5
Factor Xa Inhibitor [EPC]
2
6
Folate Analog Metabolic Inhibitor [EPC]
2
7
Integrin Receptor Antagonist [EPC]
2
8
Potassium Channel Blocker [EPC]
2
9
Programmed Death Ligand-1 Blocker [EPC]
2
10
Tumor Necrosis Factor Blocker [EPC]
2
11
Acetylcholine Release Inhibitor [EPC]
1
12
Aminoglycoside Antibacterial [EPC]
1
13
Androgen Receptor Inhibitor [EPC]
1
14
Antirheumatic Agent [EPC]
1
15
Influenza A M2 Protein Inhibitor [EPC]
1
16
Insulin Analog [EPC]
1
17
Interferon beta [EPC]
1
18
Interleukin-12 Antagonist [EPC]
1
19
Interleukin-23 Antagonist [EPC]
1
20
Kinase Inhibitor [EPC]
1
21
Neuromuscular Blocker [EPC]
1
22
Nucleoside Metabolic Inhibitor [EPC]
1
23
Platinum-based Drug [EPC]
1
24
Programmed Death Receptor-1 Blocking Antibody [EPC]
1
25
Proton Pump Inhibitor [EPC]
1
26
Purine Antimetabolite [EPC]
1
27
Thiazide Diuretic [EPC]
1
28
Vitamin B12 [EPC]
1
29
Vitamin C [EPC]
1
30
Vitamin D [EPC]
1
31
beta3-Adrenergic Agonist [EPC]
1